UnitedHealthcare’s decision to make devices from Medtronic the preferred insulin pump for type 1 diabetics has angered some patients, the Star Tribune reports. UnitedHealthcare told the newspaper that Medtronic’s devices help prevent complications, making them safer than alternatives.
Ana Gupte, an analyst with Leerink Partners, said collaborations between UnitedHealthcare and Medtronic may continue if this deal results in lower costs and improved outcomes.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.